Rubaba Hussain
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Renin-Angiotensin System Studies 1
- Co-authors
- Elizabeth L. Alexander (1 shared paper)Scott Segal (1 shared paper)Sergio Parra (1 shared paper)Erick Stanley Petersen Juárez (1 shared paper)Jaynier Moya (1 shared paper)Andrew Skingsley (1 shared paper)Gretja Schnell (1 shared paper)Jennifer E. Sager (1 shared paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Rubaba Hussain
6 papers receiving 463 citations
Rubaba Hussain's Hit Papers
Peers
Comparison fields: 5 of 66
- Infectious Diseases 258
- Neurology 50
- Cardiology and Cardiovascular Medicine 48
- Applied Microbiology and Biotechnology 4
- Endocrinology, Diabetes and Metabolism 30
Countries citing papers authored by Rubaba Hussain
This map shows the geographic impact of Rubaba Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubaba Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubaba Hussain more than expected).
Fields of papers citing papers by Rubaba Hussain
This network shows the impact of papers produced by Rubaba Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubaba Hussain. The network helps show where Rubaba Hussain may publish in the future.
Co-authors
The 9 scholars most cited alongside Rubaba Hussain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 Hit paper breakdown → | 2022 | 207 |
| 2 | 2021 | 146 | |
| 3 | RNA Interference With Zilebesiran for Mild to Moderate Hypertension Hit paper breakdown → | 2024 | 85 |
| 4 | 2025 | 16 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 5 |
About Rubaba Hussain
Rubaba Hussain is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Insect Science, Renewable Energy, Sustainability and the Environment and Obstetrics and Gynecology, having authored 6 papers that have together received 473 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Renin-Angiotensin System Studies (1 paper). The work is most often cited by research in Infectious Diseases (258 citations), Neurology (50 citations), Cardiology and Cardiovascular Medicine (48 citations), Applied Microbiology and Biotechnology (4 citations) and Endocrinology, Diabetes and Metabolism (30 citations). Rubaba Hussain has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Elizabeth L. Alexander, Scott Segal, Sergio Parra, Erick Stanley Petersen Juárez, Jaynier Moya, Andrew Skingsley, Gretja Schnell, Jennifer E. Sager and Melissa Aldinger. Their work appears in journals such as JAMA and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.